Infimer has developed a breakthrough technology and innovative processes for treating unsorted MSW and turning it into a novel thermoplastic composite material – Infimer® – which can be used as a raw material for the plastic industry.
During 2013 and 2014, Infimer conducted several production trials in order to establish and examine the process, characterize the products, validate the technology, and file the corresponding patents for its technology and products.
In a preliminary production trial, the novel polymers were produced, characterized and used by a large plastics company in manufacturing several of its end products.
During a second production trial, several tons of Infimer® were produced in a pilot line, with rented equipment and with equipment manufactured specially for the trial. The trial lasted 10 days, during which the plastics company collected polymer samples directly in order to validate the consistency of the process and the products. The plastics company tested these polymers in their R&D labs, and positive results regarding the consistency of Infimer® were obtained. The plastics company injected 30%-50% of Infimer® mixed with other plastic materials in several factories and produced plastic products which successfully passed all its QA tests. As a result of these trials, a long-term agreement was signed between Infimer and the plastics company. As part of this agreement, Infimer received significant orders, part of which being for immediate supply, and part is stipulated on meeting certain conditions.
The third step was to perform production trials in Europe and get feedback from potential European equipment manufacturers and customers. Two production trials, starting from MSW and ending by producing Infimer®, were conducted in Europe. The MSW treatment and Infimer® production is based on two main processes: (1) waste separation, and (2) production of polymers. Therefore the first process was performed in Germany using local unsorted MSW at a company that specializes in the design and production of separation tanks, grinders and squeezers. The second process, polymer production, was performed in Austria at EREMA, a company that specializes in the design and production of plastic recycling systems. The production of Infimer® was assessed by the TCKT Transfer Center for Plastic Technology in Austria.
In March 2015, the company completed a merger, by means of a share exchange, with the Tel-Aviv Stock Exchange-listed company, EZ Energy Ltd.
Following completion of the merger, Infimer became a wholly-owned subsidiary of EZ Energy, while Infimer’s shareholders became the controlling shareholders of EZ Energy (71%). On the transaction date, EZ Energy had about US$ 2.4 million in cash. On June 18, 2015, the name of the company was changed from EZ Energy Ltd. to Infimer Ltd.
After completion of the merger, Infimer began designing and building a dedicated production line in order to start supplying the open orders.
In May 2015, Infimer registered in the USA two patents (PCT) and five provisional applications for patents relating to methods of treating municipal waste and producing thermoplastic materials, biogas and biofuels from the treated waste.